We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
+8.55%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.5B
AUM Growth
+$112M
(+4.7%)
Cap. Flow
+$22.9M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
54.31%
Holding
65
New
15
Increased
17
Reduced
8
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$149M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$95.6M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$92.9M |
| 4 |
UnitedHealth
UNH
|
+$86.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$81.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$145M |
| 2 |
Labcorp
LH
|
+$92M |
| 3 |
Cigna
CI
|
+$88.6M |
| 4 |
Encompass Health
EHC
|
+$77.2M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 98.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Stryker
SYK
$130B
| $24.7M | 0.99% |
+118,550
| New | +$23M |
|
|
ARNA
27
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $23.2M | 0.93% |
+310,000
| New | +$20.7M |
|
28
Edwards Lifesciences
EW
$51.7B
| $17.9M | 0.72% |
+223,860
| New | +$17.5M |
|
29
Zymeworks
ZYME
$1.73B
| $16.1M | 0.64% |
+345,550
| New | +$11.9M |
|
30
CALL
Arcturus Therapeutics
ARCT
$211M
| $8.58M | 0.34% |
+200,000
| New | +$9.93M |
|
31
Assembly Biosciences
ASMB
$529M
| $8.54M | 0.34% |
+43,291
| New | +$10.9M |
|
32
Bristol-Myers Squibb
BMY
$132B
| $7.57M | 0.3% |
125,500
-937,000
| -88% | -$56.4M |
|
33
American Well
AMWL
$230M
| $7.41M | 0.3% |
+12,500
| New | +$6.6M |
|
34
Align Technology
ALGN
$12.3B
| $4.81M | 0.19% |
14,680
-34,610
| -70% | -$10.6M |
|
|
LONA
35
LeonaBio Inc
LONA
$72.1M
| $4.01M | 0.16% |
+21,750
| New | +$3.63M |
|
36
Dyne Therapeutics
DYN
$4.9B
| $2.42M | 0.1% |
+120,000
| New | +$2.63M |
|
37
Incyte
INCY
$24.4B
| $2.03M | 0.08% |
+22,580
| New | +$2.18M |
|
38
Outset Medical
OM
$90.8M
| $1.75M | 0.07% |
+2,333
| New | +$1.92M |
|
39
BioMarin Pharmaceuticals
BMRN
$12.3B
| $1.11M | 0.04% |
+14,600
| New | +$1.48M |
|
40
Syndax Pharmaceuticals
SNDX
$1.82B
| $475K | 0.02% |
+32,200
| New | +$491K |
|
41
Abbott
ABT
$187B
| – | – |
-638,180
| Closed | -$58.3M |
|
42
Acadia Pharmaceuticals
ACAD
$5.03B
| – | – |
-1,025,000
| Closed | -$49.7M |
|
43
Adaptive Biotechnologies
ADPT
$3.97B
| – | – |
-345,370
| Closed | -$16.7M |
|
|
44
Becton Dickinson
BDX
$48.7B
| – | – |
-621,632
| Closed | -$145M |
|
|
BLUE
45
DELISTED
bluebird bio
BLUE
| – | – |
-20,126
| Closed | -$15.9M |
|
46
BioNTech
BNTX
$23.5B
| – | – |
-503,920
| Closed | -$33.6M |
|
|
BPMC
47
DELISTED
Blueprint Medicines
BPMC
| – | – |
-743,018
| Closed | -$58M |
|
|
48
Cigna
CI
$74.6B
| – | – |
-472,360
| Closed | -$88.6M |
|
|
49
Encompass Health
EHC
$12.4B
| – | – |
-1,566,749
| Closed | -$77.2M |
|
|
GBIO
50
DELISTED
Generation Bio
GBIO
| – | – |
-10,000
| Closed | -$2.1M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q3 2020 Portfolio in Review
As of Q3 2020, HealthCor Management held 65 positions worth $2.5B, up 4.7% from $2.39B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
HealthCor Management's Q3 2020 filing shows 15 new, 17 increased, 8 reduced and 25 closed positions. Its largest new stake was Cooper Companies: 966,160 shares worth $81.4M. The largest sale was Becton Dickinson, an estimated $145M.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.
- HealthCor Management's largest Q3 2020 buy was Cooper Companies: 966,160 shares worth $81.4M.
- HealthCor Management added most to Zimmer Biomet in Q3 2020, an estimated $149M increase.
- HealthCor Management's biggest Q3 2020 reduction was Bristol-Myers Squibb, cutting an estimated $56.4M.
- HealthCor Management fully exited Becton Dickinson in Q3 2020, selling an estimated $145M.
- HealthCor Management's ten largest holdings make up 54% of its $2.5B portfolio in Q3 2020.
- HealthCor Management opened 15 new positions and closed 25 in Q3 2020.
- HealthCor Management's portfolio value rose 4.7% quarter-over-quarter to $2.5B.
Based on HealthCor Management's 13F filing for Q3 2020, filed 16 Nov 2020.